1Fujii Y, Takeuchi S, Sasaki O, et al. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage [J]. Stroke,1998 ;29(6) :160-6.
2Hallevi H, Abraham AT, Barreto AD, et al. The spot sign in intracerebral hemorrhage :the importance of looking for contrast extravasation [J]. Ce- rebrovasc Dis,2010 ; 29 ( 3 ) : 217 -20.
3Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerehral hemorrhage[J].Stroke, 1997 ;28 ( 1 ) : 1-5.
4Muooz R, Gallego J, Herrera M, et al. New perspectives on intracerebral haemorrhage[J]. An Sist Sanit Navar,2008 ;31 ( Suppl 1 ) :47-59.
5Cheung RT. Update on medical and surgical management of intracerebral hemorrhage[J]. Rev Recent Clin Trials ,2007 ;2 (3) :174-81.
6Mayer SA, Bran NC, Broderick J, et al. Safety and feasibility of recombi- nant factor VI a for acute intracerebral hemorrhage [ J ]. Stroke, 2005 ; 36 (1) :74-9.
7Mayer SA. Recombinant activated factor for acute intracerebral hemor- rhage[J]. Stroke,2007 ;38 (2 Suppl) :763-7.
8Yuan ZH, Jiang JK, Huang WD, et al. A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracere- bral hemorrhage without hemophilia [J]. Clin Neurosci, 2010 ; 17 ( 6 ) : 685 -93.
6Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group [J]. N Engl J Med, 1995, 333(24),1 581-1 587.
7Isaac AM. Re-education. Rx: activities of daily living [J]. J Kans Med Soc, 1963, 64:58-62.
8Brott T, Brodefiek J, Kothafi R, et al. Early hemorrhage growth in Patients with intracerebral hemorrhage [J ]. Stroke, 1997, 28(11) :1-5.
9Piriyawat P, Morgenstern LB, Tawn DH, et al. Treatment of acute intraeerebral hemorrhage with epsilon aminocaproic acid: a pilot study[J]. Neurocrit Care, 2004, 1(1):47-51.
10Mayer SA, Brun NC, Begtrup K, et al. Recombinant activa- ted factor Ⅶ for acute intracerebral hemorhage[J]. N Ensl J Med, 2005, 352(123) :777-785.
